Delivering Therapeutic Foresight And Results
With a long-standing history of therapeutic speciality and technological innovation, one company has transformed itself from a start-up contract research organisation into a drug development leader specialising in oncology, CNS and paediatrics, with full data services capabilities.
INC Research, a global contract research organisation, invests in its customers’ success with proven therapeutic foresight and a trusted approach to advance drug and device development. The company’s Trusted Process™ method of conducting phase 1 to 4 trials means its customers experience trial excellence, thereby helping to minimise potential risk factors and leading to more informed and confident development decisions.
Its seasoned project managers and clinicians deliver unsurpassed scientific expertise and service in a therapeutically focused environment, as well as in innovative pediatric trials. Pharmaceutical and biotechnology companies look to INC Research for functional outsourcing needs and to conduct complete customised worldwide trials that end with results of the highest integrity.
High-performance teams
The teams at INC Research are built from the brightest people in the industry with years of therapeutically focused and industry-related experience, from the company’s top scientists to its data entry group. By continually attracting the industry’s most talented individuals, the company has emerged as a leading global CRO.
The high percentage of repeat business is a testament to the quality and dedication of the INC Research team.
Customised service
A customer-centric focus is a clear, common objective across the entire INC Research organisation. Its full range of services, processes and technology are tailored to the needs of each client and their specific project requirements. For phase 1 to 4 clinical trials, INC Research provides:
- Study monitoring
- Project management
- Scientific, medical and regulatory consulting
- Cognitive services
- Pediatric services
- Product development
- Patient recruitment
- Investigator recruitment
- Medical monitoring and drug safety
- Data management
- Biostatistics
- Medical writing
- Quality assurance
Trusted results
INC Research offers a full spectrum of drug development services designed to support the unique needs of its customers. It is the disciplined approach of its Trusted Process, deployed to effectively execute customer programmes, that makes it stand out in the industry.
The four-part process, with specialised therapeutic expertise at its foundation, begins with planning and design where pre-study award activities are conducted in advance of contract execution. Thus, a selected team is fully prepared with feasibility and critical programme considerations from the start.
Phase 2 is QuickStart™, the part of INC Research’s process designed to enable the efficient movement of a project through the initial phases of a study. QuickStart provides the benefits of rapid cycle times on all project plans, building study ownership by the entire project team. Phase 3 is Programmed Acceleration™, where active recruitment and intelligent or iMonitoring kick in, along with aggressive management of critical study data.
Finally, the process wraps up with QualityFinish™, with customer deliverables presented as requested – on time and within budget.
Global presence
With a presence in 32 countries worldwide, INC Research works from 20 offices across North America, Central, Eastern and Western Europe. Through a strong network of international CRO partners, the company has the global capabilities to deploy a study on any scale, on six continents.
Equipped with knowledge of local languages, culture and regulatory requirements, project teams at INC Research provide an unsurpassed level of support to investigative sites. Backed by strong clinical experience and therapeutic expertise, the company takes a highly flexible and customised approach to clinical research by listening closely to clients and tailoring services to their unique needs and projects, from select regional services to full-service international studies.
At INC Research, the commitment to bringing new drugs to market is intense and focused. The team understands the complexities involved in clinical programmes, and has the flexibility, expertise in a number of therapeutic areas and the in-depth understanding of the full development process to handle any aspect of these trials. Whether the scope of a project is a full-service international study or product development programme, or requires only select regional services, INC Research has the resources and expertise to meet all needs.
Company profile
INC Research is based in Raleigh, North Carolina, USA, and its European headquarters is located in Maidenhead, England, UK. For more information, visit: www.incresearch.com.
< Back to Contract services index
< Back to Market Resources index
